News search
 About the CNIC 15 May 2024 Globally, cardiovascular diseases due to atherosclerosis – the build-up of plaque in arteries – are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and encourage prevention. Denmark’s Novo Nordisk Foundation has granted up to EUR 23 million to cover the first 2.5 years of the REACT initiative. The initiative is expected to run for 8 years in total |
 About the CNIC 9 Feb 2024 The National Center for Cardiovascular Research Carlos III (CNIC) is excited to announce the upcoming edition of the CNIC Conferences |
 Research 1 Feb 2024 A study published in Nature Cardiovascular Research reveals smooth muscle-derived cells as a new target for reducing the size of atherosclerotic plaque. The results open up new avenues for the design of treatments to enhance the beneficial effect of cholesterol-lowering drugs |
 |
 About the CNIC 2 Jan 2024 Juan Pedro Bolaños is Professor of Biochemistry and Molecular Biology at the University of Salamanca. |
 About the CNIC 19 Dec 2023 Dr. Carla Rothlin is Dorys McConnell Duberg Professor of Immunobiology and Professor of Pharmacology at the Yale School of Medicine, and co-leader of the Cancer Immunology Programme at Yale Cancer Centre. She studied biochemistry and pharmacology at the University of Buenos Aires, where she also undertook her postgraduate research under the direction of Dr. Ana Belén Elgoyhen, focussing on nicotinic receptors expressed in the inner ear. Later, she completed her doctorate and moved to San Diego to join Dr. Greg Lemke’s laboratory at the Salk Institute for Biological Studies. In 2009, Dr. Rothlin was named Assistant Professor in Immunobiology at Yale Medical School |
 About the CNIC 29 Nov 2023 CNIC and the i+12 Institute co-lead one of the working groups of this initiative. |
 |
 Research 20 Nov 2023 Atherosclerosis, previously believed to be an irreversible progressive disease, can be reversed if risk factors are contolled early enough |
 About the CNIC 31 Oct 2023 Dr Sancho heads the CNIC Immunobiology Laboratory, whose work focuses on research into the function of dendritic cells and macrophages, as key immune cells that modulate immunity and inflammation, and the use of these cells in immunotherapy in a wide range of diseases |
- ‹ previous
- 3 of 17
- next ›
